Medicare Enrolled
Dr. Daniel Lebovic, MD
Internal Medicine · Langhorne, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lebovic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lebovic?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lebovic
Dr. Daniel Lebovic is an internal medicine specialist in Langhorne, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lebovic performed 71,089 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lebovic received a total of $70,590 from 80 pharmaceutical and/or device companies across 608 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lebovic is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 0% volume in PA
$70,590 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗71,089
Medicare services
Top 0% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 16,400 | $43 | $139 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
13,970 | $2 | $21 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
13,950 | $0 | $6 |
| Denosumab injection (Prolia/Xgeva) | 8,940 | $19 | $69 |
| Iron infusion (Monoferric) | 5,900 | $16 | $73 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,086 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,640 | $1 | $122 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,444 | $8 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,028 | $8 | $19 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
661 | $13 | $105 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
624 | $89 | $879 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
506 | $101 | $224 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
466 | $113 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
418 | $70 | $148 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
363 | $12 | $93 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
174 | $63 | $205 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
167 | $24 | $152 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
167 | $95 | $232 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
145 | $55 | $304 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
136 | $1 | $7 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
130 | $24 | $156 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
105 | $1 | $9 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
88 | $144 | $412 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
81 | $147 | $301 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
80 | $56 | $334 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
72 | $18 | $97 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
71 | $66 | $157 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
60 | $11 | $73 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $109 | $297 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $91 | $220 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
38 | $2 | $19 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
34 | $4 | $26 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $134 | $343 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $46 | $88 |
| New patient office visit, complex (60-74 min) | 12 | $186 | $432 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.7% high complexity
84.6% medium
5.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$70,590
Total received (2018-2024)
Avg $10,084/year across 7 years
Top 2% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
608
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,306
2023
$2,361
2022
$2,105
2021
$6,710
2020
$4,584
2019
$22,382
2018
$30,142
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$218
Novartis Pharmaceuticals Corporation
$167
ABBVIE INC.
$145
Eisai Inc.
$122
E.R. Squibb & Sons, L.L.C.
$113
Janssen Biotech, Inc.
$108
Astellas Pharma US Inc
$107
PFIZER INC.
$99
Incyte Corporation
$97
Gilead Sciences, Inc.
$84
Genentech USA, Inc.
$84
Genmab U.S., Inc.
$79
Celgene Corporation
$74
Karyopharm Therapeutics Inc.
$66
Mirati Therapeutics, Inc.
$56
Stemline Therapeutics Inc.
$55
Apellis Pharmaceuticals, Inc.
$46
Daiichi Sankyo Inc.
$42
ARRAY BIOPHARMA INC
$41
Myriad Genetic Laboratories, Inc.
$40
Acrotech Biopharma Inc.
$40
Aveo Pharmaceuticals, Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
Merck Sharp & Dohme LLC
$31
Kite Pharma, Inc.
$25
MorphoSys, US Inc.
$24
PUMA BIOTECHNOLOGY, INC.
$24
BeiGene USA, Inc.
$24
Pharmacosmos Therapeutics Inc.
$23
TerSera Therapeutics LLC
$22
CSL Behring
$21
Regeneron Healthcare Solutions, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
GlaxoSmithKline, LLC.
$19
Lilly USA, LLC
$19
RECORDATI_RARE_DISEASES_INC.
$18
EMD Serono, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$16
Secura Bio, Inc.
$15
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 23.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$35,355
PFIZER INC.
$24,273
E.R. Squibb & Sons, L.L.C.
$2,067
Novartis Pharmaceuticals Corporation
$1,031
Janssen Biotech, Inc.
$606
Genentech USA, Inc.
$605
AstraZeneca Pharmaceuticals LP
$597
Astellas Pharma US Inc
$378
Daiichi Sankyo Inc.
$311
ABBVIE INC.
$284
Amgen Inc.
$272
Incyte Corporation
$240
Merck Sharp & Dohme Corporation
$233
Eisai Inc.
$214
GENZYME CORPORATION
$202
Gilead Sciences, Inc.
$193
Seagen Inc.
$182
Karyopharm Therapeutics Inc.
$175
Kite Pharma, Inc.
$169
Pharmacyclics LLC, An AbbVie Company
$167
Genmab U.S., Inc.
$150
Lilly USA, LLC
$147
Myovant Sciences Inc.
$110
Regeneron Healthcare Solutions, Inc.
$108
Celgene Corporation
$104
ARRAY BIOPHARMA INC
$103
Merck Sharp & Dohme LLC
$96
AbbVie, Inc.
$95
Stemline Therapeutics Inc.
$94
Mirati Therapeutics, Inc.
$91
Bayer Healthcare Pharmaceuticals Inc.
$87
Pharmacosmos Therapeutics Inc.
$82
Puma Biotechnology, Inc.
$78
TerSera Therapeutics LLC
$77
Takeda Pharmaceuticals U.S.A., Inc.
$71
Foundation Medicine, Inc.
$71
Mylan Institutional Inc.
$67
Apellis Pharmaceuticals, Inc.
$67
MorphoSys, US Inc.
$66
Ipsen Biopharmaceuticals, Inc
$62
GlaxoSmithKline, LLC.
$61
Blueprint Medicines Corporation
$59
Acrotech Biopharma Inc.
$57
EMD Serono, Inc.
$51
Bayer HealthCare Pharmaceuticals Inc.
$48
Seattle Genetics, Inc.
$47
G1 Therapeutics, Inc.
$43
Rigel Pharmaceuticals, Inc.
$42
Sun Pharmaceutical Industries Inc.
$42
JAZZ PHARMACEUTICALS INC.
$41
EISAI INC.
$41
Myriad Genetic Laboratories, Inc.
$40
Acrotech Biopharma LLC
$40
Aveo Pharmaceuticals, Inc.
$38
PUMA BIOTECHNOLOGY, INC.
$38
Pharmacyclics LLC, an AbbVie Company
$32
Organon LLC
$32
Dova Pharmaceuticals
$31
ImmunoGen, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Taiho Oncology, Inc.
$27
Pharming Healthcare, Inc.
$26
BeiGene USA, Inc.
$24
PharmaEssentia USA Corporation
$22
CSL Behring
$21
Array BioPharma Inc.
$21
Helsinn Therapeutics (U.S.), Inc.
$19
Heron Therapeutics, Inc.
$19
AbbVie Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
TESARO, Inc.
$18
Midatech Pharma US Inc
$17
Agios Pharmaceuticals, Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
Clovis Oncology, Inc.
$16
Spectrum Pharmaceuticals Inc.
$15
Secura Bio, Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
Alexion Pharmaceuticals, Inc.
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 87.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CALQUENCE · CARVYKTI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · FOLOTYN · FOTIVDA · FOUNDATIONONE · FULPHILA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Gelclair · Halaven · Herceptin · Hizentra · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Perjeta · Polivy · REBLOZYL · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tivdak · Trodelvy · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vitrakvi · Voranigo · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
4,154
County median income
$111,951
Nearest hospital to ZIP centroid (approximate)
ST MARY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lebovic is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lebovic experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Lebovic performed 16,400 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lebovic receive payments from pharmaceutical companies?
Yes. Dr. Lebovic received a total of $70,590 from 80 companies across 608 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lebovic's costs compare to other internal medicine physicians in Langhorne?
Dr. Lebovic's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lebovic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Langhorne
Browse internal medicine physicians in Langhorne ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology